"For more than 25 years, Texan Eye has been a leader in cataract and refractive surgery, providing sophisticated laser and lens implant surgery for patients who only trust their vision to the best. Other specialty services we offer include oculoplastics, pediatric consultations and full service diagnoses and treatment for glaucoma, retinal and corneal disorders. Texan Eye also offers comprehensive eye exams as well as contact lenses and glasses fittings for our patients."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Surface Ophthalmics, Inc.
2
Aerpio Therapeutics
1
Hoffmann-La Roche
1
Ocular Therapeutix, Inc.
1
RVL Pharmaceuticals, Inc.
1
ReGenTree, LLC
1
Silk Technologies, Ltd.
1
Clinical Trials at Texan Eye / Keystone Research, Ltd.
During the past decade, Texan Eye / Keystone Research, Ltd. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma
A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease
2021-01-11
2022-03-25
Completed
351
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Texan Eye / Keystone Research, Ltd." #1 sponsor was "Surface Ophthalmics, Inc." with 2 trials, followed by "Aerpio Therapeutics" with 1 trials
sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Ocular Therapeutix, Inc." with 1 trials sponsored and "RVL Pharmaceuticals, Inc."
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
Clinical Trials Conditions at Texan Eye / Keystone Research, Ltd.
According to Clinical.Site data, the most researched conditions in "Texan Eye / Keystone Research, Ltd." are
"Dry Eye" (2 trials), "Ocular Hypertension" (2 trials), "Blepharoptosis" (1 trials), "Dry Eye Disease" (1 trials) and "Dry Eye Syndromes" (1 trials). Many other conditions were trialed in "Texan Eye / Keystone Research, Ltd." in a lesser frequency.
Most popular intervention types in "Texan Eye / Keystone Research, Ltd." are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "0.01% RO7058584" (1 trials), "0.1% RO7058584" (1 trials), "1% RO7058584" (1 trials) and "AKB-9778" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Texan Eye / Keystone Research, Ltd.
The vast majority of trials in "Texan Eye / Keystone Research, Ltd." are
8 trials for "All" genders.
Clinical Trials Status at Texan Eye / Keystone Research, Ltd.
Currently, there are NaN active trials in "Texan Eye / Keystone Research, Ltd.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Texan Eye / Keystone Research, Ltd.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Texan Eye / Keystone Research, Ltd., 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".